How do you pay?
Which strength? Pick yours
How many tablets?

How to pay the least

From

$14.42 for 30 tablets

Generic metronidazole with the free Team Cuban Card, at pharmacies that take it. Pick the strength on your label for its own price.

What to do

  1. Get the free Team Cuban Card. It costs nothing to sign up.See the price and get the card 
  2. At a pharmacy that takes it, show the card and ask for generic metronidazole.Find a pharmacy that takes it 

Other ways

By mail, if you can wait a few days From $11.32 for 30 tablets delivered ($6.07 plus $5.25 shipping) from Cost Plus Drugs. Make a free account, then have your prescription sent there.

Open Cost Plus Drugs 

Every company’s metronidazole is rated by the FDA to work the same, so any pharmacy can fill your prescription with the one it stocks.

See every pharmacy’s price

Where to buy it

Pharmacies’ own cash prices for generic metronidazole, lowest first.

Pick up in storeDelivered

From each pharmacy’s own site, read November 17, 2026. Confirm the price before you fill.

About these prices

Prices change, can differ by store and state, and may depend on the strength and how many you take. With insurance, ask what your plan charges; it can be less.

Who makes it

10 companies sell metronidazole in this form, each one rated by the FDA as a substitute for the others. A pharmacy fills whichever one it stocks. To get a certain maker, ask for it by name; most pharmacies can order it in a day or two.

  • Alembic Pharmaceuticals250 mg, 500 mg
    How it looks, what’s in it, NDCs

    250 mg White to off white, round, 9 mm, marked “HP64”

    PackageNDC
    Bottle of 3062332-016-30
    Bottle of 5062332-016-50
    Bottle of 10062332-016-31
    Bottle of 25062332-016-61
    Bottle of 50062332-016-71
    Bottle of 100062332-016-91

    500 mg White to off white, capsule, 16 mm, marked “HP65”

    PackageNDC
    Bottle of 3062332-017-30
    Bottle of 5062332-017-50
    Bottle of 10062332-017-31
    Bottle of 50062332-017-71
    Bottle of 100062332-017-91

    Inactive ingredients: hydroxypropyl cellulose (70000 wamw), crospovidone, cellulose, microcrystalline, silicon dioxide, hydrogenated cottonseed oil, microcrystalline cellulose

    FDA label

  • Amici Pharma250 mg, 500 mg

    Made by Innogenix

    How it looks, what’s in it, NDCs

    250 mg White, round, 9 mm, marked “I / 124”

    PackageNDC
    Bottle of 10069292-207-01
    Bottle of 50069292-207-50

    500 mg Off-white, oval, 16 mm, marked “I / 125”

    PackageNDC
    Bottle of 10069292-208-01
    Bottle of 50069292-208-50

    Inactive ingredients: silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, stearic acid

    FDA label

  • Avet Pharmaceuticals250 mg, 500 mg

    Made by Somerset Therapeutics

    Product page on avetpharma.com

    How it looks, what’s in it, NDCs

    250 mg White to Off-White, round, 9 mm, marked “MCR / 104”

    PackageNDC
    Bottle of 10023155-651-01
    Bottle of 50023155-651-05

    500 mg White to Off-White, oval, 16 mm, marked “MCR / 105”

    PackageNDC
    Bottle of 10023155-652-01
    Bottle of 50023155-652-05

    Inactive ingredients: microcrystalline cellulose, crospovidone, silicon dioxide, cottonseed oil

    FDA label

  • BluePoint Laboratories250 mg, 500 mg

    Made by Unichem Pharmaceuticals

    How it looks, what’s in it, NDCs

    250 mg White, round, 10 mm, marked “U / 226”

    PackageNDC
    Bottle of 10068001-364-00

    500 mg White, oval, 18 mm, marked “U / 227”

    PackageNDC
    Bottle of 10068001-365-00
    Bottle of 50068001-365-03

    Inactive ingredients: hydroxypropyl cellulose (90000 wamw), low-substituted hydroxypropyl cellulose, hypromellose 2910 (5 mpa.s), polyethylene glycol 400, powdered cellulose, stearic acid, titanium dioxide

    FDA label

  • Chartwell RX250 mg, 500 mg

    Made by Somerset Therapeutics

    How it looks, what’s in it, NDCs

    250 mg White to Off-White, round, 9 mm, marked “MCR / 104”

    PackageNDC
    Bottle of 9062135-795-90

    500 mg White to Off-White, oval, 16 mm, marked “MCR / 105”

    PackageNDC
    Bottle of 9062135-796-90

    Inactive ingredients: microcrystalline cellulose, crospovidone, silicon dioxide, cottonseed oil

    FDA label

  • Method Pharmaceuticals250 mg, 500 mg

    Made by Innogenix

    How it looks, what’s in it, NDCs

    250 mg White, oval, 9 mm, marked “I / 124”

    PackageNDC
    Carton of 5058657-933-05
    Carton of 10058657-933-01

    500 mg White, oval, 16 mm, marked “I / 125”

    PackageNDC
    Carton of 5058657-934-05
    Carton of 10058657-934-01

    Inactive ingredients: silicon dioxide, crospovidone, magnesium stearate, microcrystalline cellulose, stearic acid

    FDA label

  • Rising Pharma Holdings250 mg, 500 mg

    Made by Aurobindo Pharma

    How it looks, what’s in it, NDCs

    250 mg White to Off-white, round, 9 mm, marked “K / 10”

    PackageNDC
    Bottle of 10016571-665-01
    Bottle of 50016571-665-50

    500 mg White to Off-white, diamond, 17 mm, marked “K / 11”

    PackageNDC
    Bottle of 10016571-664-01
    Bottle of 50016571-664-50

    Inactive ingredients: silicon dioxide, hydroxypropyl cellulose (1600000 wamw), microcrystalline cellulose, starch, corn, sodium starch glycolate type a potato, stearic acid

    FDA label

  • Teva Pharmaceuticals250 mg, 500 mg

    Made by Pliva

    How it looks, what’s in it, NDCs

    250 mg White, round, 9 mm, marked “PLIVA / 333”

    PackageNDC
    Bottle of 10050111-333-01
    Bottle of 25050111-333-06
    Bottle of 50050111-333-02

    500 mg White, oval, 16 mm, marked “PLIVA / 334”

    PackageNDC
    Bottle of 10050111-334-01
    Bottle of 50050111-334-02

    Inactive ingredients: microcrystalline cellulose, crospovidone (15 mpa.s at 5%), silicon dioxide, hydrogenated cottonseed oil

    FDA label

  • Unichem Pharmaceuticals250 mg, 500 mg

    Product page on unichemusa.com

    How it looks, what’s in it, NDCs

    250 mg White, round, 10 mm, marked “U / 226”

    PackageNDC
    Bottle of 5029300-226-46
    Bottle of 10029300-226-01
    Bottle of 25029300-226-52
    Bottle of 50029300-226-05
    Bottle of 100029300-226-10

    500 mg White, oval, 18 mm, marked “U / 227”

    PackageNDC
    Bottle of 5029300-227-46
    Bottle of 10029300-227-01
    Bottle of 50029300-227-05
    Bottle of 100029300-227-10

    Inactive ingredients: hydroxypropyl cellulose (90000 wamw), hydroxypropyl cellulose, low substituted, hypromellose 2910 (5 mpa.s), polyethylene glycol 400, powdered cellulose, stearic acid, titanium dioxide

    FDA label

  • Viona Pharmaceuticals250 mg, 500 mg

    Made by Cadila Pharmaceuticals

    Product page on vionausa.com

    How it looks, what’s in it, NDCs

    250 mg White to off-white, round, 9 mm, marked “850”

    PackageNDC
    Bottle of 10072578-007-01
    Bottle of 25072578-007-21
    Bottle of 50072578-007-05

    500 mg White to off-white, oval, 17 mm, marked “851”

    PackageNDC
    Bottle of 5072578-008-18
    Bottle of 10072578-008-01
    Bottle of 50072578-008-05

    Inactive ingredients: cellulose, microcrystalline, hydroxypropyl cellulose, low substituted, hypromellose, polyethylene glycol 3350, silicon dioxide, stearic acid, talc, titanium dioxide

    FDA label

Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.

What to say at the pharmacy

“Before you fill it, what would I pay for generic metronidazole?”

Paying cash? Ask for the cash price. With insurance, ask what your plan charges.

What it’s used for

What the FDA label says

Symptomatic Trichomoniasis. Metronidazole tablets, USP are indicated for the treatment of T. vaginalis infection in females and males when the presence of the trichomonad has been confirmed by appropriate laboratory procedures (wet smears and/or cultures).

Asymptomatic Trichomoniasis. Metronidazole tablets, USP are indicated in the treatment of asymptomatic T. vaginalis infection in females when the organism is associated with endocervicitis, cervicitis, or cervical erosion. Since there is evidence that presence of the trichomonad can interfere with accurate assessment of abnormal cytological smears, additional smears should be performed after eradication of the parasite.

Treatment of Asymptomatic Sexual Partners. T. vaginalis infection is a venereal disease. Therefore, asymptomatic sexual partners of treated patients should be treated simultaneously if the organism has been found to be present, in order to prevent reinfection of the partner. The decision as to whether to treat an asymptomatic male partner who has a negative culture or one for whom no culture has been attempted is an individual one. In making this decision, it should be noted that there is evidence that a woman may become reinfected if her sexual partner is not treated. Also, since there can be considerable difficulty in isolating the organism from the asymptomatic male carrier, negative smears and cultures cannot be relied upon in this regard. In any event, the sexual partner should be treated with metronidazole tablets in cases of reinfection.

Amebiasis. Metronidazole tablets, USP are indicated in the treatment of acute intestinal amebiasis (amebic dysentery) and amebic liver abscess.

In amebic liver abscess, metronidazole tablets therapy does not obviate the need for aspiration or drainage of pus.

Anaerobic Bacterial Infections. Metronidazole tablets, USP are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Indicated surgical procedures should be performed in conjunction with metronidazole tablets therapy. In a mixed aerobic and anaerobic infection, antimicrobials appropriate for the treatment of the aerobic infection should be used in addition to metronidazole tablets.

INTRA-ABDOMINAL INFECTIONS, including peritonitis, intra-abdominal abscess, and liver abscess, caused by Bacteroides species including the B. fragilis group (B. fragilis, B. distasonis, B. ovatus, B. thetaiotaomicron, B. vulgatus), Clostridium species, Eubacterium species, Peptococcus species, and Peptostreptococcus species.

SKIN AND SKIN STRUCTURE INFECTIONS caused by Bacteroides species including the B. fragilis group, Clostridium species, Peptococcus species, Peptostreptococcus species, and Fusobacterium species.

GYNECOLOGIC INFECTIONS, including endometritis, endomyometritis, tubo-ovarian abscess, and postsurgical vaginal cuff infection, caused by Bacteroides species including the B. fragilis group, Clostridium species, Peptococcus species, Peptostreptococcus species, and Fusobacterium species.

BACTERIAL SEPTICEMIA caused by Bacteroides species including the B. fragilis group and Clostridium species.

BONE AND JOINT INFECTIONS, (as adjunctive therapy), caused by Bacteroides species including the B. fragilis group.

CENTRAL NERVOUS SYSTEM (CNS) INFECTIONS, including meningitis and brain abscess, caused by Bacteroides species including the B. fragilis group.

LOWER RESPIRATORY TRACT INFECTIONS, including pneumonia, empyema, and lung abscess, caused by Bacteroides species including the B. fragilis group.

ENDOCARDITIS caused by Bacteroides species including the B. fragilis group.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of metronidazole tablets and other antibacterial drugs, metronidazole tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

Source: the FDA label for Metronidazole (Viona Pharmaceuticals Inc), August 13, 2024. Full label on DailyMed 

Good to know

  • Different companies’ metronidazole can look different. The FDA requires each to work the same way.
  • Don’t stop or change a medicine without talking to your pharmacist or prescriber.